Back
Rhythm Pharmaceuticals Vs. Omnicell Industry Stock Comparison
Buy
65
RYTM
Rhythm Pharmaceuticals
Last Price:
47.68
Seasonality Move:
18.45%
Buy
69
OMCL
Omnicell
Last Price:
48.74
Seasonality Move:
3.33%
Buy
65
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $49.63. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Omnicell (OMCL)
is a Buy
Is Omnicell a Buy, Sell or Hold?
- The current Omnicell [OMCL] share price is $53.08. The Score for OMCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- OMCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $49.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
OMCL Stock Price Chart
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 49.59 | Sell |
| Chaikin Money Flow: | 104653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.47 - 51.35) | Sell |
| Bollinger Bands (100): | (43.62 - 50.96) | Buy |
OMCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 77.8 | Buy |
| Chaikin Money Flow: | 1224414 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.71 - 44.73) | Buy |
| Bollinger Bands (100): | (29.66 - 44.6) | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.4 | Buy |
| 20-day SMA: | 49.45 | Buy |
| 50-day SMA: | 49.42 | Buy |
| 200-day SMA: | 44.54 | Buy |
| 8-day EMA: | 49.53 | Buy |
| 20-day EMA: | 49.7 | Sell |
| 50-day EMA: | 49.11 | Buy |
| 200-day EMA: | 43.69 | Buy |
OMCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Buy |
| 20-day SMA: | 42.08 | Buy |
| 50-day SMA: | 43.14 | Buy |
| 200-day SMA: | 33.28 | Buy |
| 8-day EMA: | 43.23 | Buy |
| 20-day EMA: | 42.42 | Buy |
| 50-day EMA: | 41.45 | Buy |
| 200-day EMA: | 38.22 | Buy |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.35 per share, and an increase next year of $1.61 per share.
Omnicell Earnings Growth & OMCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.16 per share.
Rhythm Pharmaceuticals Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Omnicell Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||